ATYR vs MAS · rev $190.0K vs P/E 18, rev $7.56B
aTyr Pharma, Inc. (ATYR) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
ATYR currently screens at market cap $471.7M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the ATYR and MAS stock pages for the full models.
Not investment advice.